BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8039448)

  • 1. [Universal donor blood].
    Wüllenweber J; Sibrowski W
    Dtsch Med Wochenschr; 1994 Jul; 119(28-29):1019. PubMed ID: 8039448
    [No Abstract]   [Full Text] [Related]  

  • 2. [Blood transfusion and monitoring. Immediate transfusion reactions. Erythrocyte transfusion].
    Riche H
    Soins; 1996 Apr; (605):23-6. PubMed ID: 8716245
    [No Abstract]   [Full Text] [Related]  

  • 3. [Modern principles of safety in erythrocytes-containing donor blood components transfusion].
    Bystrykh OA; Fedorova TA; Strel'nikova EV
    Anesteziol Reanimatol; 2013; (6):57-9. PubMed ID: 24749268
    [No Abstract]   [Full Text] [Related]  

  • 4. Donors' blood group declaration before donation can be used as a tool for electronic crossmatching.
    Arslan O
    Transfus Med; 2005 Dec; 15(6):487-92. PubMed ID: 16359420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [ABO polymorphism in blood donors in Morocco].
    Habti N; Nourichafi N; Benchemsi N
    Transfus Clin Biol; 2004 Apr; 11(2):95-7. PubMed ID: 15120106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tips for blood transfusion.
    Basavanthappa BT
    Nurs J India; 1983 Mar; 74(3):64-6. PubMed ID: 6552558
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular blood grouping.
    Daniels G
    Vox Sang; 2004 Jul; 87 Suppl1():63-6. PubMed ID: 15200607
    [No Abstract]   [Full Text] [Related]  

  • 8. Transfusion of universal donor and uncrossmatched blood.
    Barnes A
    Bibl Haematol; 1980; (46):132-42. PubMed ID: 6990911
    [No Abstract]   [Full Text] [Related]  

  • 9. After major ABO-mismatched allogeneic hematopoietic progenitor cell transplantation, erythroid engraftment occurs later in patients with donor blood group A than donor blood group B.
    Schetelig J; Breitschaft A; Kröger N; Zabelina T; Ebell W; Bornhäuser M; Haack A; Ehninger G; Salama A; Siegert W;
    Transfusion; 2005 May; 45(5):779-87. PubMed ID: 15847669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The histocompatibility problem in military blood transfusions].
    Shevchenko IuL; Danil'chenko VV; Serebrianaia NB; Nefedov VS; Zhiburt EB; Katkova IV
    Voen Med Zh; 1995 Aug; (8):26-9, 80. PubMed ID: 8571558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nondeletional ABO*O alleles frequently cause blood donor typing problems.
    Wagner FF; Blasczyk R; Seltsam A
    Transfusion; 2005 Aug; 45(8):1331-4. PubMed ID: 16078922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune haemolysis after renal transplantation secondary to ABO minor-mismatch between donor and recipient.
    Jayaranee S; Ramesh P; Nadesan V
    Singapore Med J; 2002 Aug; 43(8):421-2. PubMed ID: 12507029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABO blood group barrier in allogeneic bone marrow transplantation revisited.
    Seebach JD; Stussi G; Passweg JR; Loberiza FR; Gajewski JL; Keating A; Goerner M; Rowlings PA; Tiberghien P; Elfenbein GJ; Gale RP; van Rood JJ; Reddy V; Gluckman E; Bolwell BJ; Klumpp TR; Horowitz MM; Ringdén O; Barrett AJ;
    Biol Blood Marrow Transplant; 2005 Dec; 11(12):1006-13. PubMed ID: 16338623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenging dogma: group A donors as "universal plasma" donors in massive transfusion protocols.
    Isaak EJ; Tchorz KM; Lang N; Kalal L; Slapak C; Khalife G; Smith D; McCarthy MC
    Immunohematology; 2011; 27(2):61-5. PubMed ID: 22356521
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-D alloimmunization by weak D type 1 red blood cells with a very low antigen density.
    Mota M; Fonseca NL; Rodrigues A; Kutner JM; Castilho L
    Vox Sang; 2005 Feb; 88(2):130-5. PubMed ID: 15720611
    [No Abstract]   [Full Text] [Related]  

  • 16. ABO genotyping by minisequencing analysis.
    Ferri G; Bini C; Ceccardi S; Pelotti S
    Transfusion; 2004 Jun; 44(6):943-4. PubMed ID: 15157266
    [No Abstract]   [Full Text] [Related]  

  • 17. Transfusion reaction due to Anti-Fya in donor blood.
    Gover PA; Morton JR
    Clin Lab Haematol; 1990; 12(2):233-5. PubMed ID: 2208952
    [No Abstract]   [Full Text] [Related]  

  • 18. [The erythrocyte phenotype in ABO and Rh blood groups in blood donors and blood recipients in a hospital setting of Cameroon: adapting supply to demand].
    Tagny CT; Fongué VF; Mbanya D
    Rev Med Brux; 2009; 30(3):159-62. PubMed ID: 19642486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a strategy to limit blood donor exposure in high risk premature newborns based on clinical estimation of transfusion need.
    van Straaten HL; de Wildt-Eggen J; Huisveld IA
    J Perinat Med; 2000; 28(2):122-8. PubMed ID: 10875097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What would Karl Landsteiner do? The ABO blood group and stem cell transplantation.
    Heal JM; Liesveld JL; Phillips GL; Blumberg N
    Bone Marrow Transplant; 2005 Nov; 36(9):747-55. PubMed ID: 16044140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.